Direct-To Patient Research

Quintiles can dramatically reduce the time and cost of running
prospective observational studies using MediGuard, our direct
connection with over 2.5M patients from around the world.

Collecting prospective observational data can be time and cost intensive,
even when your study protocol is very simple. The process of identifying,
contracting and motivating investigators to recruit patients is not always so
simple, and often results in hidden costs and delays that can compromise
the most straightforward projects.

To overcome these investigator-centric problems, Quintiles has created
MediGuard, the largest direct-to-patient research platform in the world.
Through MediGuard’s direct access to over 2.5M clinically profiled and
engaged patients, Quintiles can now work directly with patients to capture
the clinical data, patient reported
outcomes and lab data you need to
complete your observational research in
record time.